Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.8 CHF | -0.89% | +2.10% | -7.38% |
Apr. 04 | Global markets live: Novo Nordisk, Ocado, Walt Disney, Apple, Tesla... | |
Apr. 04 | Medartis Issues CFH116 Million Convertible Bonds | MT |
Sales 2024 * | 244M 267M | Sales 2025 * | 287M 315M | Capitalization | 1.06B 1.16B |
---|---|---|---|---|---|
Net income 2024 * | 8M 8.76M | Net income 2025 * | 14M 15.34M | EV / Sales 2024 * | 4.42 x |
Net Debt 2024 * | 22.69M 24.86M | Net Debt 2025 * | 16.66M 18.26M | EV / Sales 2025 * | 3.73 x |
P/E ratio 2024 * |
111
x | P/E ratio 2025 * |
66.2
x | Employees | 812 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 34.53% |
Latest transcript on Medartis Holding AG
1 day | -0.89% | ||
1 week | +2.10% | ||
Current month | -2.99% | ||
1 month | -4.66% | ||
3 months | +3.87% | ||
6 months | +15.09% | ||
Current year | -7.38% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 19-08-31 | |
Dirk W. Kirsten
DFI | Director of Finance/CFO | 56 | 21-02-28 |
Chief Operating Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
H. C. Straumann
FOU | Founder | 61 | 97-11-02 |
Damien Tappy
BRD | Director/Board Member | 55 | 17-12-31 |
Marco Gadola
CHM | Chairman | 61 | 20-04-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - | |
0.00% | 34 M€ | +4.49% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 77.8 | -0.89% | 1,923 |
24-05-27 | 78.5 | +2.75% | 3,212 |
24-05-24 | 76.4 | +0.53% | 917 |
24-05-23 | 76 | -1.30% | 1,756 |
24-05-22 | 77 | +2.53% | 3,289 |
Delayed Quote Swiss Exchange, May 28, 2024 at 11:31 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.38% | 1.17B | |
+13.31% | 128B | |
-9.13% | 10.9B | |
-2.59% | 8.69B | |
+37.50% | 5.48B | |
-22.36% | 4.72B | |
-11.25% | 2.76B | |
-14.85% | 2.05B | |
-13.29% | 1.93B | |
-28.75% | 1.67B |
- Stock Market
- Equities
- MED Stock